Anzeige
Mehr »
Donnerstag, 23.10.2025 - Börsentäglich über 12.000 News
Das Comeback des Goldrauschs - diesmal ausgelöst durch eine Währungskrise
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QB4E | ISIN: IL0011651580 | Ticker-Symbol:
NASDAQ
22.10.25 | 18:39
1,210 US-Dollar
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
PAINREFORM LTD Chart 1 Jahr
5-Tage-Chart
PAINREFORM LTD 5-Tage-Chart

Aktuelle News zur PAINREFORM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
01.10.PainReform reduziert Nettoverlust deutlich - gemischte Fortschritte in Pharma- und Solarsparte1
PAINREFORM Aktie jetzt für 0€ handeln
01.10.PAINREFORM LTD. - 6-K, Report of foreign issuer-
01.10.PainReform Ltd: PainReform Provides Business Update for the Six Months Ended June 30, 2025133TEL AVIV, Israel, Oct. 01, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization...
► Artikel lesen
19.08.PainReform Stock Soars 83% On NVIDIA Partnership For AI-Driven Solar Analytics10
19.08.PainReform's DeepSolar unit joins NVIDIA Connect Program5
19.08.PainReform Ltd: PainReform/DeepSolar Accepted into NVIDIA Connect Program4
13.08.PAINREFORM LTD. - 6-K, Report of foreign issuer1
13.08.PainReform sichert sich Mehrheitsbeteiligung an LayerBio zur Weiterentwicklung von Augenmedikament3
13.08.PainReform acquires majority stake in LayerBio to advance eye surgery drug3
13.08.PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System161TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced, through its pharmaceutical division, the closing of its previously announced investment in LayerBio...
► Artikel lesen
10.07.Painreform stock falls after announcing strategic investment in LayerBio1
10.07.Painreform-Aktie fällt nach strategischer Investition in LayerBio2
10.07.PAINREFORM LTD. - 6-K, Report of foreign issuer1
07.05.PAINREFORM LTD. - 6-K, Report of foreign issuer2
07.05.PainReform Ltd: PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar Platform to Optimize One of Romania's Largest Solar Projects1
07.04.PainReform Ltd: PainReform Provides Year-End Business Update240TEL AVIV, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a specialty pharmaceutical company focused on the reformulation of established...
► Artikel lesen
05.03.PainReform Ltd: PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics351TEL AVIV, Israel, March 05, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation...
► Artikel lesen
18.02.PainReform Ltd: PainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion Opportunity269DeepSolar brings new customer base in creation, including major utility-scalesolar operators and independent power producers, whilebreaking into the residential solar market The Company remains committed...
► Artikel lesen
27.12.24PainReform Ltd: PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110432TEL AVIV, Israel, Dec. 27, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of...
► Artikel lesen
20.12.24Pre-market Movers: My Size, Nvni Group, Psyence Biomedical, Humacyte, PainReform872BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.55 A.M. ET).In the Green My Size, Inc. (MYSZ) is up over 372% at $6.43. Nvni...
► Artikel lesen
Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1